Value proposition

Accelerating access to medical innovations

We are a social enterprise committed to improving health in more than 90 countries. Our mission is to cut illness and death by speeding up access to lifesaving vaccines, medicines, diagnostics and technologies for people in underserved communities.

Using $200 million capital from British International Investment, our agile team of global health and investment experts shapes agreements that break down the barriers preventing people from accessing medical innovations.

We are independent and not-for-profit, with any operating surpluses invested into developing new agreements to accelerate access to healthcare.

global health, public health, business analysis, innovative finance, financial guarantees, and international development